PIONEER: A Phase I Study of Olaparib in Combination with Chemo-radiation in Locally Advanced Pancreatic Cancer

Trial Profile

PIONEER: A Phase I Study of Olaparib in Combination with Chemo-radiation in Locally Advanced Pancreatic Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 03 May 2017

At a glance

  • Drugs Olaparib (Primary) ; Capecitabine
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Acronyms PIONEER
  • Most Recent Events

    • 18 Sep 2015 Accrual to date is 2% as reported by United kingdom Clinical Research Network record.
    • 20 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ISRCTN: Current Controlled Trials.
    • 18 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top